ALB and neoplasm: An increased totaldose delivery to the tumor must thus be caused by an additional ormodified tumor uptake mechanism such as target binding of the albumin-boundradioligand and/or a favorable structural influence of the albumin-bindingmoiety on the tumor targeting that is independent of the albumin-bindingability.